P. Sheridan

发表

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

M. Laakso, S. Yusuf, J. Bosch, 2006, The Lancet.

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

S. Connolly, E. Themeles, G. Hankey, 2018, The New England journal of medicine.

Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism

E. Lonn, P. Sheridan, J. Ray, 2007, Annals of Internal Medicine.

Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.

S. Connolly, G. Hankey, P. Sheridan, 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study

D. Mozaffarian, S. Yusuf, P. López-Jaramillo, 2018, The Lancet.

Effect of rosiglitazone and ramipril on-cell function in people with impaired glucose tolerance ( IGT ) or impaired fasting glucose ( IFG ) : the DREAM Trial . Running title : Rosiglitazone , ramipril and-cell function

S. Yusuf, P. Sheridan, B. Zinman, 2009 .

White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries

S. Yusuf, P. López-Jaramillo, A. Dans, 2020, Diabetes Care.

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries

D. Mozaffarian, S. Yusuf, P. López-Jaramillo, 2020, BMJ Open Diabetes Research & Care.

Venous thromboembolism in association with features of the metabolic syndrome.

S. Yusuf, J. Pogue, E. Lonn, 2007, QJM : monthly journal of the Association of Physicians.

Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke

Thalia Shoshana Field, P. Sheridan, L. Gioia, 2020, Stroke.

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose

S. Yusuf, J. Bosch, G. Dagenais, 2008, Diabetes Care.

Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability: Additional Findings From the HOPE 2 Trial

E. Lonn, P. Sheridan, G. Saposnik, 2009, Stroke.

Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)

S. Yusuf, G. Dagenais, C. Held, 2008, Vascular medicine.

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries

D. Mozaffarian, S. Yusuf, P. López-Jaramillo, 2020, BMJ Open Diabetes Research & Care.

Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

S. Yusuf, H. Gerstein, P. Sheridan, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Homocysteine lowering with folic acid and B vitamins in vascular disease.

S. Yusuf, C. Held, J. Pogue, 2006, The New England journal of medicine.

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

S. Yusuf, J. Bosch, G. Dagenais, 2005, JAMA.

Effect of ramipril on the incidence of diabetes.

S. Yusuf, J. Bosch, G. Dagenais, 2006, The New England journal of medicine.

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.

S. Yusuf, C. Held, E. Lonn, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries.

S. Yusuf, P. López-Jaramillo, K. Yusoff, 2020, The American journal of clinical nutrition.

Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study

S. Yusuf, G. Dagenais, P. López-Jaramillo, 2020, Diabetes Care.

White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries

S. Yusuf, P. López-Jaramillo, A. Dans, 2020, Diabetes Care.

STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone) People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in

S. Yusuf, J. Bosch, G. Dagenais, 2011 .

Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

S. Yusuf, J. Bosch, G. Dagenais, 2009, Journal of the American College of Cardiology.

Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

S. Yusuf, J. Bosch, J. Pogue, 2006, The Canadian journal of cardiology.

Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial.

G. Guyatt, D. Xavier, A. Dans, 2021, Contemporary clinical trials.

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal

S. Yusuf, J. Bosch, G. Dagenais, 2011, Diabetes Care.

Dysglycemia and a History of Reproductive Risk Factors

S. Yusuf, P. Sheridan, H. Gerstein, 2008, Diabetes Care.

Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

S. Yusuf, J. Bosch, G. Dagenais, 2009, Journal of the American College of Cardiology.